University of Cagliari
Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis
Caocci, Giovanni;
2021-01-01
Files in This Item:
| File | Size | Format | |
|---|---|---|---|
| Ruxolitinib discontinuation syndrome, incidence, risk factors, and management in 251 pts with MF.pdf open access
Type: versione editoriale
Size 766.74 kB
Format Adobe PDF
|
766.74 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.